Rivaroxaban and warfarin achieve effective anticoagulation, as assessed by inhibition of TG and in-vivo markers of coagulation activation, in patients with venous thromboembolism-Reference-Cited by-同舟云学术

Rivaroxaban and warfarin achieve effective anticoagulation, as assessed by inhibition of TG and in-vivo markers of coagulation activation, in patients with venous thromboembolism

Published:2015-02 Issue:2 Volume:135 Page:388-393
ISSN:0049-3848
Container-title:Thrombosis Research
language:en
Short-container-title:Thrombosis Research

Author:

Arachchillage D.R.J.,Efthymiou M.,Mackie I.J.,Lawrie A.S.,Machin S.J.,Cohen H.

Funder

LUPUS UK

Bayer Healthcare

Publisher

Elsevier BV

Subject

Hematology

Reference37 articles.

1. Xarelto 20mg film-coated tablets. Summary of Product Characteristics last updated on the eMC: 06/01/2014. 6-1-2014. Ref Type: Online Source

2. High rate of unprovoked recurrent venous thrombosis is associated with high thrombin-generating potential in a prospective cohort study;Besser;J Thromb Haemost,2008

3. Prediction of recurrent venous thromboembolism by endogenous thrombin potential and D-dimer;Eichinger;Clin Chem,2008

4. Suppression of hemostatic system activation by oral anticoagulants in the blood of patients with thrombotic diatheses;Conway;J Clin Invest,1987

5. Changes of prothrombin fragment 1+2 (F 1+2) as a function of increasing intensity of oral anticoagulation–considerations on the suitability of F 1+2 to monitor oral anticoagulant treatment;Tripodi;Thromb Haemost,1998

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. DOAC–associated bleeding, hemostatic strategies, and thrombin generation assays - a review of the literature;Journal of Thrombosis and Haemostasis;2023-03

2. The effect of rivaroxaban on biomarkers in blood and plasma: a review of preclinical and clinical evidence;Journal of Thrombosis and Thrombolysis;2023-02-06

3. Thrombin generation assays to personalize treatment in bleeding and thrombotic diseases;Frontiers in Cardiovascular Medicine;2022-11-10

4. Cilioretinal artery occlusion in antiphospholipid syndrome and the decision to anticoagulate;BMJ Case Reports;2022-11

5. Role of Direct Oral Anticoagulation Agents as Thromboprophylaxis in Antiphospholipid Syndrome;Cureus;2021-10-24